Neoforma Retains Merrill Lynch & Co. to Explore Strategic Alternatives
12 1월 2005 - 6:30AM
PR Newswire (US)
Neoforma Retains Merrill Lynch & Co. to Explore Strategic
Alternatives SAN JOSE, Calif., Jan. 11 /PRNewswire-FirstCall/ --
Neoforma, Inc. (NASDAQ:NEOF), a leading provider of supply chain
management solutions for the healthcare industry, today announced
that it has retained Merrill Lynch & Co. as its financial
advisor to assist the Company in evaluating strategic alternatives,
including a possible sale or merger of the Company, in order to
achieve greater stockholder value. (Logo:
http://www.newscom.com/cgi-bin/prnh/20030226/NEOFORMALOGO )
Neoforma anticipates that any transaction will require the consent
of VHA Inc. and the University HealthSystem Consortium (UHC), two
national healthcare alliances which together own a majority of the
Company's outstanding shares. VHA and UHC are the owners of
Novation, their supply company and Neoforma's largest customer.
There can be no assurances that any particular alternative will be
pursued or that any transaction will occur, or on what terms. About
Neoforma Neoforma is a leading supply chain management solutions
provider for the healthcare industry. Through a unique combination
of technology, information and services, Neoforma provides
innovative solutions to over 1,500 hospitals and suppliers,
supporting more than $10 billion in annualized transaction volume.
By bringing together contract information and order data,
Neoforma's integrated solution set delivers a comprehensive view of
an organization's supply chain, driving significant cost savings
and better decision-making for both hospitals and suppliers. For
more information, point your browser to http://www.neoforma.com/ .
This news release contains forward-looking information within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended.
These forward-looking statements include statements related to
Neoforma's consideration of strategic alternatives. There are a
number of risks that could cause actual results to differ
materially from those anticipated by these forward-looking
statements. These risks include the risk that no strategic
alternative will ultimately be considered. Other risks are
described in Neoforma's periodic reports filed with the SEC,
including its Quarterly Report on Form 10-Q for the quarter ended
September 30, 2004. These statements are current as of the date of
this release and Neoforma assumes no obligation to update the
forward-looking information contained in this news release. NOTE:
Neoforma is a trademark of Neoforma, Inc. Other Neoforma logos,
product names and service names are also trademarks of Neoforma,
Inc., which may be registered in other countries. Other product and
brand names are trademarks of their respective owners.
http://www.newscom.com/cgi-bin/prnh/20030226/NEOFORMALOGO
http://photoarchive.ap.org/ DATASOURCE: Neoforma, Inc. CONTACT:
Rebecca Oles, media, +1-408-468-4363, or , or Amanda Mogin,
investors, +1-408-468-4251, or , both of Neoforma Web site:
http://www.neoforma.com/
Copyright
Neoforma (NASDAQ:NEOF)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Neoforma (NASDAQ:NEOF)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024
Neoforma Inc. (MM) (나스닥)의 실시간 뉴스: 최근 기사 0
More Neoforma.Com (MM) News Articles